Venture Certified
| 연구개발유형 | 2014-03-28 ~ 2016-03-27 | 20140400243 | 2014-03-28 |
| 기술평가보증기업(기금) | 2020-04-22 ~ 2022-04-21 | 20200105088 | 2014-03-28 |
| 혁신성장유형 | 2022-04-22 ~ 2025-04-21 | 20220511030047 | 2014-03-28 |
| 혁신성장유형 | 2025-04-22 ~ 2028-04-21 | 20250702030017 | 2014-03-28 |
Revenue CAGR +58.5%
| Item | 2023 | 2022 |
|---|---|---|
| Revenue | 8.8B | 5.5B |
| Operating Profit | 1.7B | 1.2B |
| Net Profit | 1.3B | 0.9B |
| Total Assets | 18B | 19B |
| Total Liabilities | 10B | 8.8B |
| Total Equity | 8.1B | 10B |
Debt Ratio Surge (+38pp YoY)
▲ 58.5%
▲ 49.1%
▼ 5.9%
▲ 43.5%
▲ 69.9%
| Name | Position | Role |
|---|---|---|
| 이영서 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 화성시",
"ceo_name": "이영서",
"certificate": [
{
"cert_number": "20140400243",
"changes": "",
"disclosure_date": "2014-03-28",
"first_cert_date": "2014-03-28",
"no": "1",
"type": "연구개발유형",
"valid_period": "2014-03-28 ~ 2016-03-27"
},
{
"cert_number": "20200105088",
"changes": "",
"disclosure_date": "2020-04-22",
"first_cert_date": "2014-03-28",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-04-22 ~ 2022-04-21"
},
{
"cert_number": "20220511030047",
"changes": "",
"disclosure_date": "2022-05-11",
"first_cert_date": "2014-03-28",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2022-04-22 ~ 2025-04-21"
},
{
"cert_number": "20250702030017",
"changes": "",
"disclosure_date": "2025-07-02",
"first_cert_date": "2014-03-28",
"no": "4",
"type": "혁신성장유형",
"valid_period": "2025-04-22 ~ 2028-04-21"
}
],
"company_name": "테크노바이오",
"corp_no": "",
"financials": {
"2022": {
"capital_stock": 1000097000,
"cost_of_sales": 306331000,
"current_assets": 960195000,
"current_liabilities": 140204000,
"gross_profit": 248155000,
"net_income": 94788000,
"net_income_bs": 94788000,
"non_current_assets": 917106000,
"non_current_liabilities": 737000000,
"non_operating_expenses": 32246000,
"non_operating_income": 10968000,
"operating_profit": 116066000,
"revenue": 554487000,
"sga_expenses": 132089000,
"total_assets": 1877301000,
"total_equity": 1000097000,
"total_liabilities": 877204000
},
"2023": {
"capital_stock": 814475000,
"cost_of_sales": 496515000,
"current_assets": 968384000,
"current_liabilities": 230381000,
"gross_profit": 382403000,
"net_income": 131183000,
"net_income_bs": 131182000,
"non_current_assets": 871120000,
"non_current_liabilities": 794649000,
"non_operating_expenses": 55232000,
"non_operating_income": 13344000,
"operating_profit": 173071000,
"revenue": 878918000,
"sga_expenses": 209332000,
"total_assets": 1839505000,
"total_equity": 814475000,
"total_liabilities": 1025030000
}
},
"industry": "그 외 기타 분류 안된 화학제품 제조업",
"investment": [],
"main_products": "연소촉진제",
"phone": "031-352-****",
"years": [
2023,
2022
]
}Data Quality: 7/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |